Compounds > 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole
Page last updated: 2024-09-03

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and Substance Withdrawal Syndrome

3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole has been researched along with Substance Withdrawal Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arneric, SP; Brioni, JD; Buckley, MJ; Decker, MW; Kim, DJ; O'Neill, AB1

Other Studies

1 other study(ies) available for 3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole and Substance Withdrawal Syndrome

ArticleYear
Anxiolytic-like effects of the novel cholinergic channel activator ABT-418.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 271, Issue:1

    Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Cognition Disorders; Diazepam; Isoxazoles; Male; Maze Learning; Mecamylamine; Mice; Nicotine; Pyrrolidines; Rats; Rats, Wistar; Substance Withdrawal Syndrome

1994